1. Home
  2. ACRV vs CMCL Comparison

ACRV vs CMCL Comparison

Compare ACRV & CMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$2.12

Market Cap

74.0M

Sector

Health Care

ML Signal

HOLD

Logo Caledonia Mining Corporation Plc

CMCL

Caledonia Mining Corporation Plc

HOLD

Current Price

$25.97

Market Cap

373.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRV
CMCL
Founded
2018
1992
Country
United States
Jersey
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
74.0M
373.1M
IPO Year
2022
2003

Fundamental Metrics

Financial Performance
Metric
ACRV
CMCL
Price
$2.12
$25.97
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.67
$28.00
AVG Volume (30 Days)
334.4K
172.1K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
2.48%
EPS Growth
15.13
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$38.54
Revenue Next Year
$568.17
N/A
P/E Ratio
N/A
$10.88
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$15.85
52 Week High
$3.56
$38.75

Technical Indicators

Market Signals
Indicator
ACRV
CMCL
Relative Strength Index (RSI) 57.57 69.36
Support Level $2.10 $25.86
Resistance Level $2.15 $26.98
Average True Range (ATR) 0.13 0.87
MACD -0.01 -0.02
Stochastic Oscillator 28.20 76.01

Price Performance

Historical Comparison
ACRV
CMCL

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

About CMCL Caledonia Mining Corporation Plc

Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. Its project includes Maligreen and Motapa.

Share on Social Networks: